Decoding Johnson & Johnson's Options Activity: What's the Big Picture? - Johnson & Johnson (NYSE:JNJ)

Core Insights - Financial giants are showing a bearish sentiment towards Johnson & Johnson, with 75% of traders indicating bearish tendencies and only 16% being bullish [1] - The analysis of options trading reveals a significant focus on a price range between $150.0 and $230.0 over the past three months [2] - Recent options activity indicates a notable bearish sentiment, with large trades in both calls and puts [7] Options Activity - The volume and open interest trends for Johnson & Johnson's options suggest a high level of liquidity and interest, particularly within the identified price range [3] - A detailed overview of the largest options trades shows that bearish sentiment is prevalent, with significant put and call volumes observed [7] Company Overview - Johnson & Johnson is recognized as the world's largest and most diverse healthcare firm, focusing on innovative medicine and medtech after divesting its consumer business [8] - The company generates over half of its total revenue from the United States, with its drug division concentrating on immunology, oncology, and neurology [8] Analyst Insights - Market analysts have set a consensus target price of $197.0 for Johnson & Johnson, reflecting cautious optimism amid the current bearish options activity [9][10] - The stock price is currently at $206.0, showing a slight increase of 0.28%, with upcoming earnings expected in 49 days [12]